Invictus RG (Singapore)’s AbbVie ABBV Stock Holding History

Invictus RG (Singapore)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-500	Closed	-$27K	–	4
2015 Q3	$27K	Sell	500 -783	-61%	-$51K	0.03%	439
2015 Q2	$86K	Sell	1,283 -817	-39%	-$53.3K	0.08%	326
2015 Q1	$123K	Buy	2,100 +833	+66%	+$50.3K	0.12%	288
2014 Q4	$83K	Buy	1,267 +685	+118%	+$43.2K	0.09%	317
2014 Q3	$34K	Sell	582 -789	-58%	-$43.8K	0.04%	370
2014 Q2	$77K	Sell	1,371 -4,344	-76%	-$228K	0.08%	346
2014 Q1	$294K	Buy	5,715 +5,284	+1,226%	+$267K	0.35%	89
2013 Q4	$23K	Sell	431 -1,433	-77%	-$70.4K	0.02%	508
2013 Q3	$83K	Buy	1,864 +1,486	+393%	+$65.9K	0.07%	349
2013 Q2	$16K	Buy	+378	New	+$16.5K	0.02%	504

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invictus RG (Singapore)'s ABBV Position: Q4 2015 in Review

Invictus RG (Singapore) sold out of AbbVie (ABBV) in Q4 2015, closing a stake of 500 shares — an estimated $27K sold.

Invictus RG (Singapore) first reported a position in ABBV in Q2 2013 and held it in 10 quarters. The position peaked at $294K in Q1 2014. 1,636 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

Invictus RG (Singapore) reported no remaining AbbVie position as of Q4 2015 after selling out during the quarter.
Invictus RG (Singapore) sold 500 AbbVie shares in Q4 2015, an estimated $27K.
Invictus RG (Singapore) first reported a position in AbbVie in Q2 2013 and held it in 10 quarters.
Invictus RG (Singapore)'s AbbVie position peaked at $294K in Q1 2014.
1,636 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on Invictus RG (Singapore)'s 13F filing for Q4 2015.